To characterize disease-relevant tau oligomeric strains, BDTOs were isolated from AD, DLB, and PSP brain tissues by immunoprecipitation using the tau oligomer–specific antibody, T22. Here, MAPT is linked to supranuclear palsy, progressive, 1.